ClinicalTrials.gg
Not yet recruitingNCT07782307Updated Aug 24, 2026

Brief Alcohol Treatment for Women Veterans in Primary Care - Open Trial

An interventional study of Brief, Integrated Intervention for Women Veterans with Unhealthy Alcohol Use in Primary Care in Unhealthy Alcohol Use, sponsored by Syracuse VA Medical Center. Not yet recruiting. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-24.

Sponsored by Syracuse VA Medical Center · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Not applicable
Ages
18 Years and older
Sex
Female
01

Study summary

The goal of this study is to develop and test a brief behavioral treatment for women Veterans with alcohol use in primary care. The study involves an open trial phase to test the intervention with a small number of participants and revise the intervention based on experience and feedback. The main questions it aims to answer are:

  • Is the treatment feasible and acceptable to women Veteran primary care patients?
  • Can the treatment help reduce alcohol use, alcohol-related problems, and improve quality of life? Researchers will deliver the intervention to women Veterans with unhealthy alcohol use in primary care. Participants will be asked to participate in the new behavioral treatment and attend 2 appointments to answer questions about their alcohol use, quality of life, other mental health symptoms, and what they thought of their behavioral treatment.
02

Conditions studied

  • Unhealthy Alcohol Use

Keywords

  • alcohol
  • integrated primary care
  • women Veterans
03

In context

Lead sponsor

Syracuse VA Medical Center is the lead sponsor of 11 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Veteran status
  • past-year Syracuse VAMC or community-based outpatient clinic (CBOC) primary care appointment
  • identify as woman OR use women's PC services
  • unhealthy alcohol use (AUDIT ≥ 7)

Exclusion criteria

Exclusion Criteria:

  • current substance use treatment outside PC
  • current psychosis, mania, or dementia (>10 on the BOMC)
  • need for a higher level of alcohol or substance use care (detoxification, residential treatment) as indicated by a) patient preference b) withdrawal symptoms that indicate a need to monitor (≥23 on the AWSC) or high risk substance use (≥27 on the ASSIST)
  • imminent risk of suicide
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
10 participants (estimated)

Study arms

  • Experimental
    Brief intervention for unhealthy alcohol use

    Participants in this arm will attend 4-9 30-minute behavioral health appointments with a behavioral health provider in an integrated primary care setting. All participants will attend 4 core alcohol-focused appointments focused on providing information and skills to manage unhealthy alcohol use. Participants may elect to attend up to 5 additional optional appointments focused on supplemental strategies to manage alcohol use or to address co-occurring mental and behavioral health concerns.

    Behavioral: Brief, Integrated Intervention for Women Veterans with Unhealthy Alcohol Use in Primary Care

Interventions

  • BehavioralBrief, Integrated Intervention for Women Veterans with Unhealthy Alcohol Use in Primary Care

    The intervention consists of 4-9 30-minute behavioral health appointments with a behavioral health provider in an integrated primary care setting. It includes 4 core alcohol-focused appointments focused on providing information and skills to manage unhealthy alcohol use that have been adapted from existing evidence-based treatments in integrated primary care and specialty care. Participants may elect to attend up to 5 additional optional appointments focused on supplemental strategies to manage alcohol use or to address co-occurring mental and behavioral health concerns, including mood, trauma, sleep, and pain.

06

What researchers measure

Primary outcomes

  1. Change in self-reported quality of life from baseline to post-treatment

    Quality of life will be assessed by the abbreviated World Health Organization Quality of Life Assessment (WHOQOL-BREF), a 26-item self-report measure of QoL in the past 2 weeks in 4 areas (social, physical, psychological, and environment) on a 1-5 scale. Higher scores indicate better quality of life.

    Time frame: Baseline to post-treatment (approximately 8-12 weeks after baseline)

  2. Change in self-reported alcohol-related problems from baseline to post-treatment

    Alcohol problems will be assessed by the Short Inventory of Problems-Revised (SIP-R)147, a 17-item self-report measure of frequency of alcohol problems on a 0-3 scale. Higher scores indicate more frequent alcohol-related problems.

    Time frame: From baseline to post-treatment (approximately 8-12 weeks after baseline)

  3. Change in self-reported alcohol-related functional impairment from baseline to post-treatment

    Alcohol-specific functional impairment will be assessed by the Addiction Severity Index - Lite, a semi-structured interview developed among Veterans in substance use treatment that assesses alcohol and drug use and problems and 5 areas of functioning: medical, legal, psychiatric, employment, and family/social. Higher scores indicate greater alcohol-related functional impairment.

    Time frame: Baseline to post-treatment (approximately 8-12 weeks after baseline)

  4. Feasibility - average session length

    Length of sessions will be measured to test if the average is within guidelines for integrated primary care treatment (30 minutes maximum)

    Time frame: For the duration of the intervention period, 8-18 weeks post-baseline

  5. Intervention fidelity

    An independent rater will listen to session tapes and record if each essential element was delivered on a checklist.

    Time frame: For the duration of the intervention period, 8-18 weeks post-baseline

  6. Self-reported patient acceptability of the intervention

    Patient acceptability will be assessed with the Client Satisfaction Questionnaire (CSQ), an 8-item self-report measure. Acceptability ratings of at least "moderate" on the majority (5/8) of items on the CSQ will be considered acceptable.

    Time frame: After completing the behavioral health treatment, 8-18 weeks post-baseline

Secondary outcomes

  1. Self-reported change in alcohol consumption from baseline to post-treatment

    Alcohol use will be assessed with the Timeline Followback (TLFB), a calendar-based measure that records standard drinks consumed each day in the past month to yield percent of drinking days, average drinks per drinking day, percent of heavy drinking (i.e., ≥4 drinks/occasion) days, and a variable indicating if alcohol use is above NIAAA-recommendations.

    Time frame: Baseline to post-treatment (approximately 8-12 weeks after baseline).

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Yes — Once all data collection is complete and the coded database is finalized, IPD will be shared according to PI discretion. For instance, IPD may be shared to be used in meta-analyses or other review papers. No identifiable participant information will be shared.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

Time frame: The data will be available once the database is finalized and will remain available in the future.

Access criteria: Access to the data can be obtained by emailing the PIs and describing the reason the data is needed.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Sep 2026; primary completion for Sep 2027, 12 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 17, 2026
First posted
Aug 24, 2026
StartEst.
Sep 2026
Primary completionEst.
Sep 2027
CompletionEst.
Sep 2027
Last update
Aug 24, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07782307
Lead sponsor
Syracuse VA Medical Center
Responsible party
Sponsor
First posted
Aug 24, 2026
Start date
Sep 2026 (estimated)
Primary completion
Sep 2027 (estimated)
Completion
Sep 2027 (estimated)
Last update
Aug 24, 2026

Study contacts

Katherine A Buckheit, PhD
Contact
katherine.buckheit@va.gov
315-425-4400 ext. 56742

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion